readthroughSign in
CompanyAUTLNasdaqLondon, X0

Autolus Therapeutics plc

Autolus Therapeutics develops engineered T cell therapies for cancer and autoimmune diseases using proprietary programming technologies.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 10Latest story